and/or

54 Blog posts found

Feature

With MSK Leading the Way, Precision Medicine Links Lab Research to Patient Care

Therapies that target genetic alterations in tumors are showing promise for many cancer patients, but challenges in developing these new treatments remain.

In the Lab

Targeting DNA Repair in Breast Cancer: PARP Inhibitors and Beyond

Scientists are looking to exploit defects in DNA repair as an Achilles’ heel in cancer.

A drawing of a DNA molecule with enzymes.

Feature

Movember Fuels Conversations and Research into Men’s Health, Including Cancer

As a survivor of testicular cancer, MSK employee Greg Mason is giving back to the cancer community by helping to raise awareness for men’s health.

Younger man with his arm around an older man.

In the Clinic

Targeting Pancreatic Cancer: An Increased Focus on Developing New Clinical Trials

Pancreatic cancer is difficult to treat, but researchers are focused on developing treatments that are personalized based on each individual patient’s disease.

Q&A

What You Should Know about Metastatic Breast Cancer

Medical oncologist Chau Dang explains that patients living with metastatic breast cancer have more treatment options than ever before.

Chau Dang

Feature

What You Need to Know about Male Breast Cancer

MSK experts discuss risk factors, symptoms, and treatment for male breast cancer.

Medical oncologist Ayca Gucalp

Feature

6 Myths about Chemotherapy

Chemotherapy is among the most commonly prescribed, and commonly misunderstood, cancer treatments. It’s time to revise what you thought you knew.

Woman preparing for chemotherapy with nurse and caregiver at Memorial Sloan Kettering Westchester

In the Clinic

How Research Is Driving the Latest Treatments for Sarcoma

Surgeon and researcher Aimee Crago discusses the latest treatments for different types of soft tissue sarcoma, including liposarcoma and desmoid tumors.

MSK Surgeon Aimee Crago

In the Clinic

New Targeted Drug Therapy for Advanced Sarcoma Extends Survival by Nearly a Year

Learn more about olaratumab, promising drug that has been shown to extend survival for people with advanced soft tissue sarcoma by nearly a year in a phase II clinical trial.

MSK physician Aimee Crago consults with two colleagues.

In the Lab

New Lung Cancer Therapy May Target Previously Untreatable Tumors

Researchers are developing uses for a drug that could benefit many people with lung cancer.

Colored x-ray of lung cancer